FF vs JAZZ · rev $243.3M vs P/E 1988, rev $4.07B
FutureFuel Corp (FF) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
FutureFuel Corp (FF) is a specialty chemicals company listed on NYSE.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported FF revenue for 2024-12-31 was $243.3M. Net income was $15.5M. Revenue was up 164.5% from 2023-12-31 to 2024-12-31. FF currently screens at market cap $185.5M.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
FF currently screens at market cap $185.5M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the FF and JAZZ stock pages for the full models.
Not investment advice.